Kidney Function Tests: eGFR, Creatinine, Cystatin C, uACR, and Urinalysis

How blood and urine tests assess kidney filtration, kidney damage, electrolyte balance, and chronic kidney disease risk

Kidney function tests work best as a set, not as a single number. Blood creatinine is used to estimate glomerular filtration rate (eGFR); cystatin C can add clarity when creatinine may be misleading; urine albumin-to-creatinine ratio (uACR) looks for albumin leakage; and urinalysis can reveal blood, protein, cells, casts, crystals, or signs of infection. A result outside a reference interval is not automatically chronic kidney disease (CKD). Clinicians interpret the pattern, the person’s health context, and whether an abnormality persists for at least three months or is supported by other evidence of kidney damage.^[1]

Part of the Ulta Lab Tests Knowledge Center

Kidney results often appear alongside metabolic, cardiovascular, diabetes, liver, and blood-count findings. For the wider testing landscape, begin with the complete guide to lab tests and blood work. Related guides explain diabetes and prediabetes blood tests, heart health blood tests, liver function tests, and CBC and anemia blood tests. These connections matter because diabetes and high blood pressure are major CKD risk factors, cardiovascular and kidney risk overlap, liver disease and medicines may influence interpretation, and anemia can accompany advanced CKD or have another cause.

Kidney testing: key facts at a glance

Measure	Main question	Important caution
Creatinine-based eGFR	How much blood are the kidneys estimated to filter?	It is an estimate and can be distorted by unusual muscle mass, recent meat intake, intense exercise, supplements, some medicines, or rapidly changing kidney function.
Cystatin-C-based or combined eGFR	Would a second filtration marker refine the estimate?	Cystatin C has different non-kidney influences, including corticosteroid use and untreated thyroid disease.
uACR	Are the kidneys leaking albumin into urine?	Exercise, fever, infection, urinary bleeding, marked hyperglycemia, and short-term blood-pressure changes can temporarily raise it.
Urinalysis and urine microscopy	Is there blood, protein, glucose, ketones, inflammation, infection, cells, casts, or crystals?	A dipstick is a screening tool; microscopy, culture, repeat testing, imaging, or clinical evaluation may be needed.
Electrolytes and related chemistry	Are fluid, acid-base, mineral, or metabolic patterns abnormal?	These results are not kidney-specific and may become urgent depending on severity, symptoms, and clinical context.[11]

What are kidney function and chronic kidney disease tests?

The kidneys remove waste and excess water, regulate electrolytes and acid-base balance, help control blood pressure, support red-blood-cell production through erythropoietin, and activate vitamin D. No single routine laboratory value measures every one of these functions. Kidney evaluation therefore combines markers of filtration, markers of kidney damage, urine findings, metabolic chemistry, symptoms, medical history, medicines, and sometimes imaging or biopsy.

CKD is defined by abnormalities of kidney structure or function that have health implications and are present for at least three months. It is classified by cause, glomerular-filtration category, and albuminuria category. An eGFR below 60 mL/min/1.73 m² that persists, or evidence of kidney damage such as persistent albuminuria, can support the diagnosis. An eGFR of 60 or higher does not exclude CKD when other kidney-damage markers are present, while G1 or G2 filtration categories alone do not establish CKD without such evidence.^[1]

Testing can serve different purposes:

• Screening and risk assessment: looking for reduced filtration or albuminuria in people at higher risk, including many people with diabetes or hypertension.
• Diagnostic support: evaluating an unexpected result, urinary symptoms, edema, blood in urine, or a suspected systemic condition.
• Confirmation: repeating an unexpected eGFR, uACR, or urine abnormality and using a second filtration marker when appropriate.
• Baseline testing: documenting kidney status before a medicine, procedure, pregnancy-related evaluation, or other clinical decision when a clinician recommends it.
• Monitoring: following known kidney disease, diabetes, hypertension, a medicine that can affect kidney function or electrolytes, or recovery after an acute illness.
• Prognosis and treatment planning: combining eGFR, albuminuria, trajectory, cause, comorbidities, and other findings to estimate risk and guide follow-up.
• Acute evaluation: investigating a possible sudden decline. Stable outpatient equations and trend rules cannot replace urgent assessment when kidney function is changing quickly.

The National Institute of Diabetes and Digestive and Kidney Diseases describes blood eGFR and urine albumin assessment as central components of CKD evaluation.^[3][4]

Blood tests and urine tests answer different questions

Blood markers primarily help estimate filtration and evaluate the chemical consequences of impaired regulation. Creatinine and cystatin C are filtered from blood; equations use one or both to estimate GFR. Blood urea nitrogen, sodium, potassium, chloride, carbon dioxide/bicarbonate, calcium, phosphorus, glucose, and albumin add context, but each can change for reasons unrelated to kidney disease.

Urine markers look for leakage and sediment abnormalities. A spot uACR adjusts urine albumin for urine concentration and is preferred over urine albumin concentration alone for most CKD risk assessment. A urine protein-to-creatinine ratio (uPCR) estimates total protein rather than albumin specifically. Urinalysis and microscopy can reveal findings that filtration estimates do not show, including hematuria, pyuria, casts, and crystals.

Because filtration and damage are different dimensions, a normal-looking eGFR does not rule out albuminuria, and a low eGFR does not explain its cause. The most informative first look is often a paired blood filtration estimate and urine albumin assessment, interpreted with the clinical picture.^[1]

What kidney tests may—and cannot—show

What a well-chosen test set may show

• A lower-than-expected estimated filtration level.
• Albumin or other protein loss in urine.
• Blood, white blood cells, casts, crystals, or organisms in urine.
• Electrolyte, bicarbonate, mineral, glucose, or albumin patterns that need follow-up.
• Whether a change is persistent, improving, worsening, or stable when results are trended.
• Whether a second filtration marker changes confidence near a clinical decision threshold.

What laboratory testing cannot determine by itself

• The exact cause of an abnormal result.
• Whether a structural problem, obstruction, stone, or tumor is present; imaging may be necessary.
• Whether one isolated abnormality is chronic.
• Whether symptoms are safe to manage without an examination.
• The right medicine, dose, or treatment plan for an individual.
• True measured GFR with perfect precision; routine eGFR equations are estimates.

False positives, false negatives, incidental findings, and normal results despite early or localized disease are possible. Testing too broadly can create unrelated abnormalities that lead to anxiety or unnecessary follow-up. The goal is not to order every available marker; it is to choose the smallest set that answers a defined question.

Who may need kidney testing?

Testing frequency is individualized. Common reasons to discuss testing with a clinician include:

• Diabetes, high blood pressure, cardiovascular disease, obesity, or a family history of kidney disease.
• Known CKD, a previous episode of acute kidney injury, recurrent stones, or structural urinary-tract disease.
• Older age together with other risk factors or a prior downward trend.
• Medicines that require kidney-based dosing or can affect kidney function or electrolytes.
• Autoimmune disease, systemic infection, cancer, plasma-cell disorders, or another condition that can involve the kidneys.
• Foamy urine, visible blood in urine, swelling, a major change in urination, flank pain, or unexplained fatigue—although symptoms may require prompt clinical rather than self-directed evaluation.

For diabetes, the American Diabetes Association recommends at least annual uACR and eGFR assessment in all people with type 2 diabetes and in people with type 1 diabetes of at least five years’ duration; people with established CKD generally need more frequent monitoring based on stage and clinical context.^[13] Screening outside recognized risk groups is a shared clinical decision, not a reason to order an unlimited kidney panel.

A tiered approach to kidney testing

Use tier	Typical components	When the tier may be useful
Common first-line	Creatinine with eGFR, uACR, urinalysis; often BUN and electrolytes as part of general chemistry	Risk-based screening, baseline assessment, or monitoring of common chronic conditions.
Confirmatory or risk-refining	Cystatin C with eGFR, combined creatinine–cystatin C eGFR, repeat early-morning uACR	When creatinine may be less reliable, the result is near a decision threshold, or an unexpected abnormality needs confirmation.
Targeted	uPCR, urine microscopy, urine culture, mineral-bone chemistry, creatine kinase, selected immune or protein studies	When symptoms, dipstick findings, stage, medicine exposure, or a suspected cause supports the choice.
Specialist-directed	Timed urine collection, measured clearance, stone-risk urine studies, imaging, genetic testing, or kidney biopsy	When routine results do not answer the question or a specific disease process is suspected.
Emerging or not broadly validated	Novel injury biomarkers and consumer “kidney wellness” scores	Usually research, specialty, or limited-use settings; they should not replace guideline-supported blood and urine assessment.
Generally not appropriate as broad screening	Large immune, genetic, stone, or 24-hour urine panels without a defined indication	These may produce incidental findings and are best chosen after history, examination, and first-line results.

The eGFR and uACR risk matrix: filtration and damage together

KDIGO classifies stable adult kidney status using GFR categories and albuminuria categories. These categories support risk stratification; they are not a self-diagnosis tool, and the same category can carry different risk depending on cause, age, comorbidities, trajectory, and other markers.^[1]

Category	eGFR, mL/min/1.73 m²	General description
G1	90 or higher	Normal or high; does not establish CKD without another marker of kidney damage.
G2	60–89	Mildly decreased; does not establish CKD without another marker of kidney damage.
G3a	45–59	Mildly to moderately decreased.
G3b	30–44	Moderately to severely decreased.
G4	15–29	Severely decreased.
G5	Below 15	Kidney failure category; clinical assessment is essential.

Category	uACR, mg/g	General description
A1	Below 30	Normal to mildly increased.
A2	30–300	Moderately increased.
A3	Above 300	Severely increased.

Risk generally rises as eGFR falls and uACR rises. Albuminuria can signal risk even when eGFR is in G1 or G2, and a low eGFR can carry risk even when uACR is A1. A clinician may also consider hematuria, structural abnormalities, the rate of change, and an externally validated kidney-failure risk equation in appropriate CKD stages.

One abnormal eGFR does not automatically establish CKD

A single low eGFR may reflect acute illness, dehydration, a medicine effect, laboratory variation, or a transient creatinine change. One elevated uACR may occur after strenuous exercise, fever, infection, urinary bleeding, or short-term metabolic stress. KDIGO recommends confirming unexpected low eGFR, elevated ACR, or hematuria rather than assuming chronic disease from one measurement.^[1][2]

Persistence for at least three months is central to the definition of CKD, but that does not mean every concerning result should simply wait three months. A substantial new change, a rapidly rising creatinine, severe electrolyte abnormality, markedly reduced urine output, or symptoms of acute illness may require same-day or urgent evaluation.

Creatinine versus cystatin C: when each marker helps

Creatinine is produced from muscle metabolism and is widely available. Adult laboratories commonly calculate a race-free creatinine-based eGFR from age, sex, and serum creatinine. Because creatinine production varies, an estimate may be less reliable in people with very high or very low muscle mass, limb loss, paralysis, severe malnutrition, bodybuilding, or rapidly changing physiology. Recent cooked meat, creatine supplements, intense exercise, and medicines that reduce tubular creatinine secretion can also change the value without a matching change in true filtration.^[7][9]

Cystatin C is produced by nucleated cells and is less directly tied to muscle mass. It may be useful when creatinine is likely biased or when greater precision would affect a decision. It is not influence-free: corticosteroids, untreated thyroid disease, and other non-GFR factors can affect it.^[8]

A combined creatinine–cystatin C equation is generally more accurate and less biased than either marker alone and is particularly useful when eGFR is near a clinical decision threshold, such as medicine dosing or referral planning.^[5] The best estimate still depends on the patient and the question; a clinician may choose measured GFR for decisions that demand more accuracy.

Approach	Strength	Important limitation
Creatinine-based eGFR	Available, inexpensive, and familiar for routine trending.	May be biased by muscle mass, diet, supplements, exercise, and some medicines.
Cystatin-C-based eGFR	Provides a filtration estimate with different non-GFR influences.	Can be affected by corticosteroids, thyroid status, and other conditions.
Combined eGFR	Often improves accuracy and precision, especially near a decision threshold.	Requires both markers and still remains an estimate.

Kidney function test guide

The tables below organize tests by purpose. Each named test or panel links to its corresponding Ulta Lab Tests product page. Review the current product page and collection instructions before ordering. A product page does not determine whether a test is appropriate for an individual.

Filtration and urine-damage tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Creatinine Test Blood; common first-line marker.	Measures serum creatinine and supports a creatinine-based eGFR. Used for screening, baseline assessment, trends, medicine dosing context, and monitoring.	No special preparation was listed on the verified product page. Muscle mass, cooked meat, creatine, strenuous exercise, hydration, acute illness, and some medicines can influence interpretation.
Albumin Random Urine Test with Creatinine Spot urine; common first-line damage marker.	Calculates uACR to estimate albumin leakage while adjusting for urine concentration. Used in diabetes and CKD risk assessment and monitoring.	No special preparation was listed on the verified product page. An early-morning clean-catch sample is often preferred; avoid intense exercise beforehand, and disclose fever, infection, urinary bleeding, menstruation, or major short-term glucose or blood-pressure changes.
Cystatin C Test with eGFR Blood; confirmatory or risk-refining.	Measures cystatin C and reports a cystatin-C-based filtration estimate. Useful when creatinine may be biased or confirmation could change a decision.	No special preparation was listed on the verified product page. Corticosteroids, untreated thyroid disease, and other non-GFR factors may influence cystatin C.
Estimated Glomerular Filtration Rate (eGFR) with Creatinine and Cystatin C Blood; higher-precision estimate.	Uses both filtration markers. Often helpful near clinical decision thresholds or when the two single-marker estimates disagree.	No special preparation was listed on the verified product page. The result remains an estimate and inherits non-GFR influences from both markers.
Protein Total Random Urine Test with Creatinine Spot urine; targeted.	Estimates total urinary protein as uPCR. It may add information when non-albumin protein is suspected or a clinician wants total-protein monitoring.	Do not treat uPCR and uACR as interchangeable. Collection conditions and transient proteinuria matter; follow the instructions for the specific ordered test.
Urinalysis Complete Test Urine; common first-line screening.	Assesses physical and chemical features and may include microscopic findings. Can detect blood, protein, glucose, ketones, leukocyte esterase, nitrite, cells, casts, crystals, or bacteria.[12]	Use clean-catch technique when instructed. Dipstick reactions and sample delay can affect results; positive findings may need microscopy, culture, repeat testing, or imaging.
Urinalysis Microscopic Test Urine; targeted sediment examination.	Looks for red and white blood cells, epithelial cells, casts, crystals, and microorganisms. The pattern can help narrow possibilities but is rarely diagnostic alone.	Collection quality and processing time matter; contamination can mislead.
Creatinine Clearance Test Timed urine plus blood; specialist-directed.	Estimates clearance from timed urine creatinine and serum creatinine. It may be considered when equations are unsuitable, though measured clearance can overestimate true GFR.	Incomplete or over-collected urine is a major source of error. Exact timing, total volume, and a paired blood sample are critical.

Chemistry, electrolyte, and mineral tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Urea Nitrogen (BUN) Test Blood; common chemistry marker.	Measures urea nitrogen, a waste product affected by filtration and urea production. Often interpreted with creatinine and the clinical context.	Protein intake, gastrointestinal bleeding, catabolic illness, hydration, liver function, and medicines can change BUN independently of GFR.
Sodium Test Blood; common electrolyte.	Helps assess water balance and neurologic risk. Abnormalities may reflect intake, losses, hormones, medicines, heart or liver disease, or kidney handling.	Serum sodium reflects water balance more than total body sodium; severe abnormalities may be emergencies.
Potassium Test Blood; common electrolyte.	Assesses a tightly regulated electrolyte important for muscle and heart electrical activity. Kidney disease and many medicines can raise or lower it.	Hemolysis, fist clenching, and collection problems can falsely elevate a result. Marked abnormalities require prompt clinical review.
Chloride Test Blood; common electrolyte.	Interpreted with sodium and bicarbonate to assess fluid and acid-base patterns.	No special preparation was listed on the verified product page. Changes are not kidney-specific and need the broader electrolyte pattern. See the focused chloride blood-testing guide.
Carbon Dioxide Test Blood; bicarbonate surrogate on routine chemistry.	Helps assess acid-base balance. Lower values may occur with metabolic acidosis, while higher values can occur in other acid-base states.	No special preparation was listed on the verified product page. Collection and handling, respiratory conditions, gastrointestinal losses, medicines, and other disorders affect interpretation.
Calcium Test Blood; total calcium.	Supports assessment of mineral balance. In CKD it is interpreted with phosphorus, parathyroid hormone, vitamin D, and albumin.	No special preparation was listed on the verified product page. Total calcium is affected by albumin and pH and does not always reflect biologically active calcium.
Calcium Ionized Test Blood; biologically active calcium.	May clarify calcium status when protein binding or acid-base changes make total calcium difficult to interpret.	No special preparation was listed on the verified product page. Collection and rapid handling are important because pH changes affect ionized calcium.
Phosphate (as Phosphorus) Test Blood; targeted by CKD stage and context.	Assesses phosphorus balance. Retention may become more relevant in advanced CKD and is interpreted with calcium, parathyroid hormone, and vitamin D.	Diet, timing, hormones, cellular shifts, and medicines influence the result.
PTH Intact Test Blood; targeted mineral-bone assessment.	Helps evaluate parathyroid response and CKD-related mineral and bone disorder in the appropriate stage and context.	Interpret trends with calcium, phosphorus, vitamin D, kidney function, assay method, and treatment—not in isolation.
Vitamin D 25-Hydroxy Total Test Blood; risk-based or targeted.	Assesses vitamin D status. It may be relevant when evaluating mineral-bone abnormalities, but it is not a direct filtration marker.	Supplements, season, sun exposure, absorption, body composition, and assay differences can influence the result.
Albumin Test Blood; general chemistry and nutrition/inflammation context.	Measures serum albumin. Low levels may reflect urinary loss but also liver disease, inflammation, nutrition, protein loss elsewhere, or fluid status.	No special preparation was listed on the verified product page. It is not the same as urine albumin and is not a stand-alone kidney-function measure.
Glucose Test Blood; metabolic-risk context.	Helps evaluate glycemia, a major driver of kidney risk in diabetes. It does not measure filtration or kidney damage directly.	Timing relative to food, acute illness, stress, and medicines affects interpretation.
Uric Acid Test Blood; risk-based or targeted.	May support gout or stone evaluation and can rise with reduced kidney excretion. A level alone does not diagnose a kidney stone or explain CKD.	Diet, alcohol, cellular turnover, medicines, and kidney handling affect the result.
Creatine Kinase Total Test Blood; symptom- or exposure-directed.	Assesses muscle injury when rhabdomyolysis is suspected; severe muscle breakdown can contribute to acute kidney injury.	No special preparation was listed on the verified product page. Exercise, injections, injury, seizures, and medicines can elevate CK; symptoms may require urgent assessment.
Urine Culture Test Urine; symptom-directed.	Looks for bacterial growth when urinary infection is suspected and may help guide antimicrobial selection.	Collect before antibiotics when clinically feasible and follow clean-catch instructions; contamination and prior antibiotics can affect results.

Timed urine and stone-focused tests

Test and quick facts	What it shows and how it is used	Preparation, influences, and limitations
Protein Total 24 Hour Urine Test with Creatinine Timed urine; targeted.	Estimates total daily protein loss and uses urine creatinine to help assess collection adequacy.	Missed or extra collections can invalidate the estimate. Follow exact start/stop, storage, and medication instructions from the laboratory and clinician.
Calcium 24 Hour Urine Test Timed urine; stone or mineral evaluation.	Assesses daily urinary calcium in selected stone, parathyroid, or mineral evaluations.	Diet, sodium intake, supplements, medicines, and collection completeness matter.
Uric Acid 24 Hour Urine Test Timed urine; selected stone evaluation.	Measures daily urinary uric acid to help characterize stone risk in the appropriate context.	Diet, medicines, collection completeness, and urine volume affect interpretation.
Oxalic Acid 24 Hour Urine Test Timed urine; selected stone evaluation.	Assesses urinary oxalate, one contributor to calcium oxalate stone risk.	Diet, supplements, gastrointestinal disease, handling, and collection completeness can influence results.
Stone Analysis Passed or removed stone; targeted.	Identifies stone composition and may guide prevention strategies.	Requires a recovered specimen; composition does not by itself explain every cause of recurrence.
StoneRisk® Panel Timed urine panel; specialist-directed.	May combine urine volume and lithogenic or protective factors to characterize recurrent-stone risk.	Exact contents and collection requirements vary; review the specific panel and follow its preparation instructions.

How clinicians choose kidney tests by purpose

Educational framework—not a diagnostic or treatment algorithm. The following examples show how the question changes the test set.

Clinical question	Often-considered starting point	Possible next step if indicated
Risk-based CKD screening	Creatinine-based eGFR plus spot uACR; urinalysis and general chemistry when appropriate.	Repeat abnormal findings, review blood pressure and diabetes status, and refine with cystatin C or other evaluation when it would change management.
Unexpected low eGFR	Review prior values, symptoms, hydration, medicines, supplements, muscle factors, and recent illness.	Repeat testing, urinalysis/uACR, cystatin C or combined eGFR, and clinical evaluation based on severity and trajectory.
Albumin or protein on urine testing	Quantify with uACR; consider uPCR when total or non-albumin protein is relevant.	Confirm persistence, examine sediment, and evaluate diabetes, blood pressure, infection, systemic disease, or other causes.
Blood or inflammatory findings in urine	Repeat a properly collected sample and obtain microscopy when appropriate.	Culture, imaging, urologic or nephrologic evaluation depending on symptoms, persistence, and sediment pattern.
Known CKD monitoring	eGFR trajectory and uACR, plus chemistry guided by stage, cause, medicines, and complications.	Anemia, mineral-bone, acid-base, nutrition, or kidney-failure risk evaluation as clinically indicated.
Possible stone	Symptoms, examination, urinalysis, selected blood tests, and imaging.	Stone composition and timed urine evaluation after the acute event or for recurrent/high-risk disease.

Individual tests versus panels

An individual marker can answer a focused question and reduce incidental findings. A panel can be efficient when several related measurements are needed, but panel names do not guarantee identical contents across laboratories or products. Review the exact current product page before ordering.

Panel or option	Potential role	Important limitation
Basic Metabolic Panel Test	Often groups glucose, calcium, electrolytes, BUN, and creatinine.	Exact panel contents should be reviewed before ordering. A metabolic panel does not replace uACR or urinalysis.
Comprehensive Metabolic Panel Test - CMP	Adds liver-related proteins and enzymes to common metabolic chemistry; useful when a broader baseline is intended.	The verified product page says fasting is preferred but not required. It remains broader than kidney assessment and does not measure urine albumin.
Electrolyte Panel Test	May focus on sodium, potassium, chloride, and carbon dioxide/bicarbonate.	Panel contents vary; it does not estimate filtration unless creatinine is included separately.
Renal Function Panel Test	May combine filtration, electrolyte, albumin, and phosphorus measures.	Panel contents, specimen requirements, and preparation can vary; review the specific panel before ordering.
Kidney Profile, Kidney Profile Test - Expanded, and KH-1 Kidney Function Panel	Potentially bundle blood and urine markers at different breadths.	Names and contents can differ. Review the exact components and do not treat these panels as interchangeable.

Kidney test name and abbreviation crosswalk

Term	Meaning	Do not confuse with
eGFR	Estimated glomerular filtration rate, usually calculated from creatinine, cystatin C, or both.	Measured GFR or creatinine clearance.
uACR or ACR	Urine albumin-to-creatinine ratio.	Serum albumin or total urine protein.
uPCR, UPCR, or PCR	Urine protein-to-creatinine ratio.	uACR or polymerase chain reaction.
UA	Urinalysis.	Urine albumin measurement alone.
Urine microscopy	Microscopic examination of urine sediment.	Dipstick-only urinalysis.
BUN	Blood urea nitrogen.	Creatinine or eGFR.
CO2 on a chemistry panel	Usually total carbon dioxide, used as a bicarbonate surrogate.	Arterial or venous blood-gas measurement.

Preparation, temporary influences, and analytical limitations

Preparation depends on the exact order. Follow the current product page and laboratory instructions, and tell the ordering clinician about medicines, nonprescription drugs, supplements, recent illness, pregnancy, intense exercise, dietary changes, and collection problems. Do not stop a prescribed medicine or intentionally dehydrate for testing unless the prescribing clinician directs you to do so.

Influence	Possible effect	Practical response
Dehydration or acute illness	May raise creatinine or BUN and alter electrolytes or urine concentration.	Report the context; urgent symptoms need clinical evaluation, and repeat testing may be appropriate after recovery.
Cooked meat or creatine	May temporarily increase serum creatinine.	Follow preparation instructions and disclose recent intake when an unexpected result occurs.
Intense exercise or muscle injury	Can increase creatinine, CK, urine blood signal, or urine albumin.	Avoid strenuous exercise before urine albumin collection when advised; seek care for severe muscle pain, weakness, or dark urine.
Unusual muscle mass or limb loss	Can bias creatinine-based eGFR.	Discuss cystatin C, a combined estimate, or measured GFR if precision would change a decision.
Corticosteroids or untreated thyroid disease	May affect cystatin C independent of filtration.	Interpret with medication and thyroid context rather than assuming the cystatin result is definitive.
Menstruation, urinary bleeding, infection, or fever	Can affect uACR, dipstick blood, protein, white cells, or culture.	Report the condition and repeat a properly collected sample when clinically appropriate.
Collection or handling error	Can contaminate urine, alter cells/casts, produce hemolysis, or invalidate timed urine.	Follow clean-catch and storage instructions; recollect when sample quality is doubtful.
Medicines	May alter kidney hemodynamics, tubular creatinine secretion, potassium, sodium, or urine findings.	Provide a complete list and let a clinician decide whether timing, dose, or monitoring changes are needed.

The direct-access lab testing guide explains general ordering, preparation, and specimen-collection expectations. Availability, eligibility, and exact instructions can vary; use the current product page and seek clinician guidance when testing concerns symptoms or a treatment decision.

How to understand kidney test results

Start with the reason for testing, then read the result in five layers:

1. Confirm the analyte, specimen, unit, and method. A urine ratio is not the same as a blood concentration, and a dipstick result is not a quantitative measurement.
2. Compare with the correct reference interval or guideline threshold. Reference intervals describe the laboratory’s comparison population; clinical decision thresholds are chosen for risk or action and may not match a printed flag.
3. Check prior results. Direction and rate of change can be more informative than a single value.
4. Look for a coherent pattern. Pair eGFR with uACR and urine findings, then integrate electrolytes, blood pressure, diabetes status, symptoms, and medicines.
5. Decide whether the result needs confirmation, routine follow-up, or urgent care. Severity, symptoms, and trajectory set the pace.

For a fuller explanation of flags, units, trends, reference intervals, and decision limits, use the guide to how to read and understand lab results.

Reference intervals versus decision thresholds

A laboratory may not flag every clinically meaningful uACR or eGFR category, and a flagged electrolyte can range from minor to urgent. Conversely, a result inside a reference interval does not rule out kidney disease when the trend, urine sediment, imaging, or symptoms are concerning. Never compare values across reports without checking units and methods.

Fictional results walkthrough

Suppose a fictional adult has a creatinine-based eGFR in the G2 category, a uACR in A2, and no symptoms. G2 alone would not establish CKD, but A2 albuminuria may represent kidney damage if it persists. A sensible interpretation is not “kidney failure” and not “everything is normal.” It is: confirm collection conditions, review diabetes and blood pressure, repeat the urine measurement as directed, examine the trend, and consider other findings. If the repeat uACR returns to A1 after a urinary infection resolves, the interpretation changes. If A2 persists for at least three months, it supports CKD classification even though filtration remains in G2.

Now suppose a different fictional adult has a sudden large creatinine rise, reduced urine output, vomiting, and weakness. The chronic-risk matrix is not the first task. That pattern may represent an acute problem and requires prompt clinical assessment.

When not to order more kidney tests on your own

• When severe symptoms or a markedly abnormal known result require urgent care rather than another outpatient panel.
• When a recent clinician-directed test already answers the question and there is no reason to expect a meaningful change.
• When a novel biomarker or large autoimmune, genetic, or stone panel has no defined indication.
• When a timed urine collection cannot be completed accurately.
• When the real need is imaging, examination, medication review, or specialist evaluation.

More data are not automatically better. Unnecessary testing can create false alarms, duplicate work, and delay the evaluation that is actually needed.

When repeat or confirmatory testing may be needed

Repeat testing is common because biological and analytical variation are real. KDIGO advises confirmation of unexpected low eGFR, elevated ACR, or hematuria.^[1] The timing depends on severity and context:

• Prompt repeat or assessment: a large new change, acute illness, marked electrolyte abnormality, or possible acute kidney injury.
• Confirmation after a transient influence resolves: uACR after fever, infection, urinary bleeding, or strenuous exercise; creatinine after an unusual exposure when safe and appropriate.
• Chronicity confirmation: persistence for at least three months when CKD is being considered and no urgent issue supersedes that timeline.
• Alternative-marker confirmation: cystatin C or a combined equation when creatinine is likely biased or accuracy near a threshold matters.
• Method escalation: measured GFR, imaging, microscopy, timed urine, or biopsy when routine estimates cannot answer the clinical question.

Do not repeat a dangerous result without seeking guidance. The care team may need to act first, confirm with a properly collected sample, review medicines, or obtain an electrocardiogram or imaging.

When professional or urgent care may be needed

Contact a clinician promptly for a substantial unexpected change in kidney function, persistent blood or protein in urine, new swelling, declining urine output, or recurrent urinary symptoms. Seek urgent or emergency care for symptoms such as:

• Very little or no urine, especially with illness or swelling.
• Shortness of breath, chest pain, fainting, severe weakness, confusion, or new palpitations.
• Severe vomiting or diarrhea with inability to keep fluids down.
• Fever with flank pain, vomiting, or feeling severely ill.
• Dark urine with severe muscle pain or weakness after exertion, injury, heat exposure, or a medicine change.
• A laboratory result that the reporting service or clinician identifies as critical.

This page cannot determine whether a symptom or result is an emergency. If in doubt, use local emergency services or urgent clinical advice rather than waiting for another self-ordered test.

Kidney-stone evaluation as a kidney-testing subtopic

Laboratory testing can support stone evaluation, but it does not confirm or locate an obstructing stone. Diagnosis may use history, examination, urine and blood testing, and imaging. Imaging can identify a stone’s location and whether it blocks the urinary tract.^[14]

During an acute episode, urinalysis may show blood or signs of infection, while blood tests can assess kidney function, electrolytes, calcium, and uric acid when relevant. Fever, infection signs, uncontrolled pain, vomiting, a solitary kidney, pregnancy, or reduced urine output changes the urgency. After a stone is passed or removed, composition analysis and a targeted 24-hour urine evaluation may help people with recurrent or high-risk stones. These tests should be selected with a clinician; they are not routine CKD screening.

Explore the kidney function and CKD knowledge center

• Chronic kidney disease: stages, causes, symptoms, and tests
• Kidney health in diabetes: why eGFR and uACR matter
• Metabolic health, weight loss, and GLP-1 monitoring

This pillar remains the broad guide to kidney filtration, albuminuria, and urinalysis. The related articles above provide focused context for CKD, diabetes, and metabolic health.

How Ulta Lab Tests may help

When direct-access laboratory testing is available and appropriate, a person may use current Ulta Lab Tests pages to review available tests and preparation information. Product availability, state eligibility, specimen requirements, listed services, and instructions can change and must be confirmed on the current page before ordering. Direct-access testing does not replace a clinician when symptoms, medication decisions, pregnancy, acute illness, or abnormal results require individualized care.

Start with a defined question, choose only the markers that answer it, and arrange clinical follow-up before testing when a result could require urgent interpretation or treatment.

Questions to ask a clinician about kidney results

• Is this result new, persistent, or part of a trend?
• Do I have both a filtration estimate and a urine albumin measurement?
• Could muscle mass, diet, exercise, illness, a supplement, or a medicine affect the result?
• Would cystatin C or a combined estimate change a decision?
• Does the urine finding need confirmation, microscopy, culture, imaging, or specialist review?
• How soon should testing be repeated, and what symptoms should trigger urgent care?
• Do any medicines need kidney-based dosing or electrolyte monitoring?
• What blood-pressure, diabetes, cardiovascular, or lifestyle factors are most important for my risk?

Frequently asked questions

What is the best test for kidney function?

There is no single best test for every purpose. Creatinine-based eGFR estimates filtration, uACR looks for albumin leakage, and urinalysis evaluates urine chemistry and sediment. Cystatin C or a combined equation may refine filtration when creatinine is less reliable or a decision needs more precision.

Can you have kidney disease with a normal eGFR?

Yes. Persistent albuminuria, urine-sediment abnormalities, structural abnormalities, or other markers of kidney damage can meet CKD criteria even when eGFR is 60 or higher. G1 and G2 categories alone do not establish CKD without evidence of damage.

Does one low eGFR mean CKD?

Not necessarily. CKD generally requires persistence for at least three months or other chronic evidence. A new low value can reflect acute illness, dehydration, medicines, or measurement variation and may need prompt evaluation rather than delayed routine repetition.

Why is uACR important?

uACR estimates urine albumin loss and predicts kidney and cardiovascular risk independently of eGFR. It can identify kidney damage before filtration is substantially reduced. Because it varies, an unexpected elevation commonly needs confirmation.^[6]

How should I prepare for a urine albumin measurement?

Follow the laboratory’s exact instructions. An early-morning clean-catch specimen is often preferred. Avoid intense exercise for 24 hours when advised, and report fever, infection, urinary bleeding, menstruation, or major short-term glucose or blood-pressure changes because they can temporarily raise albumin.^[6]

When does cystatin C add value?

It can help when creatinine may be biased by unusual muscle mass or when a more precise estimate could change medicine dosing, referral, or another decision. A combined creatinine–cystatin C equation often performs better than either marker alone, but cystatin C also has non-kidney influences.

Is a high BUN the same as kidney failure?

No. BUN is affected by filtration but also by hydration, protein intake, bleeding in the digestive tract, catabolic illness, liver function, and medicines. Interpret it with creatinine, eGFR, symptoms, and the broader chemistry pattern.^[10]

Is urinalysis the same as uACR?

No. A routine urinalysis surveys several chemical and microscopic features. uACR quantitatively compares urine albumin with urine creatinine and is more sensitive for lower levels of albuminuria. Depending on the question, both may be appropriate.

Does blood on a urine dipstick always mean red blood cells are present?

No. The dipstick blood reaction can reflect red blood cells, hemoglobin, or myoglobin. Microscopy and the clinical context can help distinguish possibilities. Menstrual contamination and collection issues also matter.

Do kidney blood tests require fasting?

Many individual kidney markers do not require fasting, but a broader panel or another test ordered at the same time might. Follow the exact current instructions. The directly verified comprehensive metabolic panel page states that fasting is preferred but not required.

Should I drink extra water before testing?

Do not deliberately overhydrate or dehydrate. Maintain usual hydration unless a clinician or collection instruction says otherwise. Excess water can dilute urine, while dehydration can alter blood and urine results.

How often should kidney tests be repeated?

Frequency depends on risk, current category, rate of change, cause, medicines, and symptoms. Many people with diabetes need at least annual eGFR and uACR assessment, while established CKD or a new abnormality may require more frequent monitoring. A clinician should set the interval.

Can a blood or urine test diagnose a kidney stone?

Laboratory findings can support evaluation, but imaging is often needed to locate a stone and assess obstruction. Fever, uncontrolled pain, vomiting, or reduced urine output warrants prompt assessment.

Can I calculate eGFR myself from creatinine?

Online calculators can illustrate an estimate, but use the laboratory-reported value and confirm the equation, age range, units, and clinical context. Pediatric equations differ, and rapidly changing kidney function makes stable-state equations unreliable.^[5]

Can I improve a kidney result before retesting?

The goal is an accurate result, not a temporarily “better” number. Do not stop medicines, change supplements, or manipulate hydration without guidance. Follow collection instructions, disclose temporary influences, and address the underlying health issue with a clinician.

Main takeaways

• Creatinine/eGFR estimates filtration; uACR measures albumin leakage; urinalysis and microscopy reveal different kinds of urine abnormalities.
• Creatinine and cystatin C have different non-kidney influences, and a combined equation can improve confidence when precision matters.
• CKD generally requires an abnormality that persists for at least three months or other evidence of chronic kidney damage.
• A single abnormal result should be interpreted for severity, symptoms, trend, temporary influences, and the need for confirmation.
• Product and panel names are not interchangeable; verify the exact specimen, contents, and preparation before ordering.
• Urgent symptoms or a critical result need clinical care, not another self-directed panel.

Primary references

1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
2. KDIGO 2024 Top 10 Takeaways: Evaluation of CKD.
3. NIDDK: Tests and Diagnosis for Chronic Kidney Disease.
4. NIDDK: Identify and Evaluate Patients with Chronic Kidney Disease.
5. NIDDK: Estimated GFR Calculators and Current Equations.
6. National Kidney Foundation: Urine Albumin-Creatinine Ratio.
7. National Kidney Foundation: Estimated Glomerular Filtration Rate.
8. National Kidney Foundation: Cystatin C.
9. MedlinePlus: Serum Creatinine Measurement.
10. MedlinePlus: BUN (Blood Urea Nitrogen).
11. MedlinePlus: Electrolyte Panel.
12. MedlinePlus Medical Encyclopedia: Urinalysis.
13. American Diabetes Association Standards of Care in Diabetes—2026: Chronic Kidney Disease and Risk Management.
14. NIDDK: Diagnosis of Kidney Stones.

Editorial Disclosure, Authorship, and Medical Note

Ulta Lab Tests provides direct-access laboratory testing. Product links are included when they match the educational topic; purchasing a test is not a substitute for diagnosis, treatment, or urgent medical care.

Written by: John R. | Originally published: August 1, 2026 | Last updated: August 7, 2026

Medical note: This guide is educational. A clinician should select and interpret testing in the context of symptoms, diagnoses, medications, pregnancy status, nutrition, hydration, and prior results. Do not start, stop, or change a prescription based on this article or one laboratory result.